We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Phreesia Inc (PHR) USD0.01

Sell:$24.38 Buy:$24.39 Change: $0.51 (2.13%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Sell:$24.38
Buy:$24.39
Change: $0.51 (2.13%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Sell:$24.38
Buy:$24.39
Change: $0.51 (2.13%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Phreesia, Inc. is a provider of software solutions. The Company offers a software-as-a-service (SaaS) based technology platform, namely Phreesia Platform, which offers healthcare services to clients with a suite of integrated solutions that manage patient access, registration and payments. Its platform provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. It facilitates patient visits in over 2,800 healthcare services across all 50 states. It serves an array of healthcare services clients of all sizes across over 25 specialties, ranging from single-specialty practices, including internal and family medicine, urology, dermatology, and orthopedics to large, multi-specialty groups, and health systems, as well as regional and national payers and other organizations that provide other types of healthcare-related services.

Contact details

Address:
1521 Concord Pike, Suite 301 Pmb 221
WILMINGTON
19803
United States
Telephone:
+1 (646) 7479959
Website:
https://www.phreesia.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PHR
ISIN:
US71944F1066
Market cap:
$1.34 billion
Shares in issue:
56.39 million
Sector:
Health Care Technology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Chaim Indig
    Chief Executive Officer, Director
  • Balaji Gandhi
    Chief Financial Officer
  • Evan Roberts
    Chief Operating Officer
  • Amy VanDuyn
    Senior Vice President - Human Resources
  • David Linetsky
    Senior Vice President - Life Sciences
  • Jack Callahan
    Chief Technology Officer
  • Janet Gunzburg
    Principal Accounting Officer
  • Audrey Gato
    Vice President - Client Solutions
  • Allison Hoffman
    General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.